We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMC
2701
Del Monte Corp
DMC
$1.54B
| $297K | ﹤0.01% |
10,657
+4,645
| +77% | +$163K |
|
2702
CG Oncology
CGON
$6.51B
| $297K | ﹤0.01% |
+4,185
| New | +$274K |
|
|
NYAX
2703
Nayax
NYAX
$1.91B
| $297K | ﹤0.01% |
4,529
-13,263
| -75% | -$878K |
|
2704
Invesco Large Cap Value ETF
PWV
$1.88B
| $295K | ﹤0.01% |
+3,893
| New | +$286K |
|
2705
Booz Allen Hamilton
BAH
$8.67B
| $295K | ﹤0.01% |
4,855
-39,825
| -89% | -$3.04M |
|
2706
CALL
Blackstone
BX
$101B
| $294K | ﹤0.01% |
2,500
-300
| -11% | -$36K |
|
2707
Cineverse
CNVS
$54M
| $294K | ﹤0.01% |
+99,025
| New | +$255K |
|
2708
Alpha Pro Tech
APT
$53.9M
| $293K | ﹤0.01% |
+52,113
| New | +$273K |
|
|
PPTA
2709
Perpetua Resources
PPTA
$3.1B
| $292K | ﹤0.01% |
14,087
-6,237
| -31% | -$169K |
|
2710
Driven Brands
DRVN
$2.18B
| $292K | ﹤0.01% |
+20,966
| New | +$276K |
|
2711
Travelers Companies
TRV
$76.3B
| $291K | ﹤0.01% |
+882
| New | +$267K |
|
|
UHT
2712
Universal Health Realty Income Trust
UHT
$572M
| $291K | ﹤0.01% |
+6,627
| New | +$272K |
|
|
ADAG
2713
Adagene
ADAG
$234M
| $290K | ﹤0.01% |
+69,100
| New | +$260K |
|
2714
WisdomTree Japan SmallCap Dividend Fund
DFJ
$434M
| $289K | ﹤0.01% |
+2,742
| New | +$290K |
|
2715
Takeda Pharmaceutical
TAK
$58.5B
| $289K | ﹤0.01% |
+18,000
| New | +$298K |
|
2716
Ardelyx
ARDX
$973M
| $288K | ﹤0.01% |
56,495
-1,544,362
| -96% | -$9.43M |
|
2717
H.B. Fuller
FUL
$2.85B
| $286K | ﹤0.01% |
+4,911
| New | +$302K |
|
|
TGEN
2718
Tecogen Inc
TGEN
$97.5M
| $286K | ﹤0.01% |
54,806
-152,661
| -74% | -$765K |
|
|
AAMI
2719
Acadian Asset Management
AAMI
$3.27B
| $286K | ﹤0.01% |
3,998
| – | – |
|
|
PSUS
2720
Pershing Square USA
PSUS
| $284K | ﹤0.01% |
+7,600
| New | +$304K |
|
2721
Alpha and Omega Semiconductor
AOSL
$772M
| $284K | ﹤0.01% |
6,000
-14,400
| -71% | -$578K |
|
2722
4D Molecular Therapeutics
FDMT
$808M
| $284K | ﹤0.01% |
21,342
+4,614
| +28% | +$45K |
|
2723
Eastern Bankshares
EBC
$4.97B
| $283K | ﹤0.01% |
12,707
-834,266
| -98% | -$16.9M |
|
2724
iShares US Oil & Gas Exploration & Production ETF
IEO
$633M
| $283K | ﹤0.01% |
2,573
-6,401
| -71% | -$743K |
|
2725
F&G Annuities & Life
FG
$3.16B
| $282K | ﹤0.01% |
+10,600
| New | +$290K |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.